Introduction: Hip dip filler treatment depends on deep support and tissue-plane planning, not simply adding surface volume to the trochanteric area.
When patients point to a hip dip, they are usually describing a local contour break between the upper buttock and the outer thigh. The area can look more noticeable after weight loss, but the underlying cause is often anatomical: the position of the greater trochanter, the shape of the iliac crest, and how muscle and fat sit around the hip. For injectors and clinical technique researchers, the practical question is not whether to add volume, but where that volume should sit and what it should support. this guide explains the structural logic of hip dip and trochanteric depression filling, the role of deep support, and the risk-awareness principles that shape safe treatment planning.
A hip dip is not a simple fat deficiency. It is a transition zone where the pelvis, femur, and surrounding soft tissue create a natural concavity. The greater trochanter gives the outer hip its bony landmark, while the gluteal muscles sit above and behind it. Between those structures, the surface contour can dip inward even when the buttock has adequate volume. This is why adding filler only to the most visible depression rarely creates a natural result. The depression is part of a larger line that runs from the lower back through the buttock and down the lateral thigh. Treating it as an isolated hole misses the shape that surrounds it. Treating this area as a local structural problem changes the plan. The goal is to rebuild a smooth transition, not to enlarge the whole buttock. A clinician may need to support the upper trochanteric region, blend into the lateral hip, and preserve the natural projection of the gluteal area. That is a different task from overall buttock augmentation, which focuses on central volume and projection. Hip dip correction is more like restoring a missing bridge between two existing contours. The right product and the right layer matter because the shape has to hold under movement, pressure, and sitting. A contour that looks good only when the patient stands still is not a reliable result.
Deep support is the part of hip dip treatment that decides whether the result looks stable or superficial. In this region, the filler is often placed in the subcutaneous layer or in a supraperiosteal plane, depending on the patient's anatomy and the clinician's assessment. Deep placement creates a foundation that the surface tissue can drape over. Without that foundation, surface volume can look lumpy or separate from the surrounding hip. With it, the contour change can read as a natural extension of the patient's existing shape rather than a patch placed on top of a depression.
When filler is placed deeply, it acts more like a support column than a surface patch. The trochanteric depression often needs this support because the area is exposed to movement and compression. A high-density monophasic cohesive gel is designed for this kind of deep body contouring. BELLA Sub-Skin, for example, is described as a high-density monophasic cohesive hyaluronic acid body filler with stated uses that include hip reshaping and soft tissue depression correction. It is available in 10ml/box and 20ml/box formats. The key idea is that a cohesive gel can hold its shape in the deep plane while the clinician uses smaller amounts near the surface to blend the edges.
Layer choice is not a technical detail; it decides how the added volume behaves. Superficial placement in a moving area can increase the risk of visible irregularity and may make the hip look wider rather than smoother. Deeper placement, by contrast, supports the contour from below and allows the surface to remain soft. The clinician also has to decide how much volume belongs above the trochanter, how much belongs lateral to it, and how much is needed to blend into the buttock. Those choices are anatomy-led. They depend on the patient's bone structure, soft tissue thickness, and the specific shape of the depression. A plan that ignores those layers can add volume without improving the contour.
Risk reduction in hip filler procedures starts with anatomy. The trochanteric region contains vessels that must be respected, and deep injection increases the importance of knowing where those vessels run. Clinicians often use a cannula for deep placement, inject slowly, and deposit small aliquots rather than pushing a large bolus under pressure. These steps are clinical precautions, not guarantees. They lower the chance of vascular compromise and reduce the risk of filler moving into unintended planes. A high-density cohesive gel can support the treatment plan, but technique and layer selection remain the first line of safety. Hyaluronidase reversal is a clinical risk-management option that should be available when deep filler is used. Migration risk is also managed through volume discipline. The hip is a high-movement area, and placing too much product too superficially can encourage spreading. Deep support with a cohesive gel is intended to keep the product in the planned plane, while smaller superficial passes refine the transition. This is why hip dip treatment should not be confused with whole-buttock augmentation. The local structure, the chosen layer, and the amount placed at each level all shape the final contour. For clinical teams comparing a hyaluronic acid body filler manufacturer, the useful question is whether the product is designed for deep body placement and cohesive support, not just how many milliliters a box contains.
Hip dips and trochanteric depressions are local structural contour problems. They are caused by the relationship between bone, muscle, and soft tissue, and they require a treatment plan that respects those layers. Deep support creates the foundation; surface blending refines the transition. Risk awareness, careful layer selection, and realistic expectations matter more than simply adding volume. When clinicians choose a hyaluronic acid body filler for this area, they should look for a gel that supports deep placement and cohesive contouring, and they should treat vascular safety as an active part of the procedure. BELLA Sub-Skin is one example of a body filler described for hip reshaping and soft tissue depression correction, available in 10ml and 20ml formats.
A：Hip dips are usually caused by anatomy rather than a single missing fat pocket. The greater trochanter, the iliac crest, the gluteal muscles, and the surrounding fat create a natural transition zone. Weight loss or aging can make the dip more visible, but the underlying shape is structural. That is why treatment focuses on rebuilding a smooth contour instead of simply filling one spot.
A：Deep support gives the hip contour a stable base. When filler is placed in the correct deep plane, the surface tissue can drape over it more naturally, and the result is less likely to look like a separate lump. It also helps the clinician avoid putting too much product superficially in a high-movement area. The goal is a smooth transition, not just extra volume.
A：Clinicians reduce vascular risk by knowing the local anatomy, using a cannula when appropriate, injecting slowly, and placing small amounts at a time. They also keep hyaluronidase available as a clinical risk-management option. These precautions lower risk, but they do not make the procedure risk-free. Careful layer selection and respect for the vascular map are central to safe hip filler treatment.
Hip dip clinical strategy and volume distribution
Anatomical layers and vascular complication prevention
Clinical risk prevention and hyaluronidase reversal
